Mr. Ron Ozols reports

EVITRADE ANNOUNCES DIVIDEND RECORD DATE FOR 2ND SUBSIDIARY COMPANY

Evitrade Health Systems Corp. has set the second subsidiary company share record distribution date for holders of record at Tuesday, April 4, 2017. The company will be trading ex dividend of the second subsidiary company as of Friday, March 31, 2017.

As per the shareholder- and court-approved plan of arrangement the second subsidiary company for the Voice of Heart electronic health platform is to be distributed pro rata to shareholders of record on the share record distribution date and the ratio of the distribution to existing shares held to be determined by management. Management is pleased to report that the distribution shall be on a 1:1 basis.

The purpose as per the plan of arrangement for the second subsidiary company is to acquire the memorandum of understanding and any assets as determined by the definitive agreement from the MOU for intellectual property in regards to the Voice of Heart electronic medical platform.

For further information shareholders can reference the information circular dated Feb. 6, 2017.

As voted for and approved by all shareholders at the annual general and special meeting, the record dates for each of the subsidiary company shares distribution is subject to change and any final date is to be determined by management. The remaining three subsidiary companies for the clinical studies, data security, and the cannabidiol and plant oils extraction from the industrial hemp or cannabis farm are expected to be announced shortly.

Also, for clarification in the previous news release March 23, 2017, for the acquisition of the Voice of Heart, Cannabis IP, Cannabis Farm assets and any new securities issued under service agreements are restricted and subject to hold requirements of a minimum of four months plus one day as per Canadian Securities Exchange regulations.

About Evitrade Health Systems Corp.

Evitrade (formerly Auxellence Health Corp.) was founded in 2013 to provide on-line digital health care services for resolving common health problems. The current markets are weight loss, high blood pressure, high blood glucose and heart arrhythmia.

We seek Safe Harbor.